Translational Oncology (M.Sc.) at Trinity College Dublin

This M.Sc. program in Translational Oncology will provide high-quality training for basic scientists and clinicians in the theoretical and practical aspects of the causes and treatment of cancer. A major focus of the programme is the cellular, genetic and epigenetic basis of cancer. The course also covers the scientific and clinical challenges pertinent to the management of site specific cancers, and all aspects of cancer treatment from standard therapies to ‘individualised’ molecular targeted and immune-based therapies. The focus of the course is research led teaching in aspects of translational cancer research.

This innovative M.Sc. program in Translational Oncology is aimed at scientists and doctors who wish to: develop their research skills, broaden their expertise in oncology, develop advanced knowledge in specific areas of scientific, translational and clinical oncology. This course will offer an opportunity for graduates from a variety of backgrounds to specifically train in translational oncology. Modules are taught using a variety of methods including lectures, tutorials, workshops and laboratory practicals. Lectures are provided by leaders in the field of translational oncology from both scientific and medical backgrounds. The core modules are Cellular and Molecular Oncology, Cancer Epigenetics, Disease Specific Cancers, Radiation / Chemotherapy and Molecular Targeted Therapies, Tumour Immunology, Molecular Pathology and Imaging, Clinical Statistics and Research Skills. Students can tailor the course to their interests with optional modules in Obesity, metabolism and Physical Activity, Genomic Instability in childhood and adult cancer, Cancer Drug Development, Tumour Microenvironment, Clinical Pharmacology and Therapeutic toxicities, and Clinical Trials and Health Economics. Students will be required to submit a dissertation based on a research project conducted in one of the many oncology groups located within or affiliated with Trinity College Dublin and Trinity Translational Medicine Institute.